Private Capital Management LLC decreased its holdings in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 1.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,152,346 shares of the company’s stock after selling 13,375 shares during the quarter. Harrow Health accounts for approximately […]
Prelude Capital Management LLC boosted its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 6.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 46,456 shares of the company’s stock after purchasing an additional 2,753 shares during the quarter. Prelude Capital Management LLC […]
Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 5,800 shares of the company’s stock in a transaction that occurred on Monday, August 14th. The shares were acquired at an average price of $17.05 per share, with a total value of $98,890.00. Following the completion of the transaction, the chief executive […]
Harrow Health (NASDAQ:HROW – Free Report) had its price objective upped by LADENBURG THALM/SH SH from $33.70 to $34.40 in a report published on Thursday morning, FlyOnTheWall reports. HROW has been the subject of a number of other research reports. B. Riley upped their price target on Harrow Health from $42.00 to $45.00 and gave […]
Harrow Health, Inc. (NASDAQ:HROW – Get Rating) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 2,890,000 shares, an increase of 30.8% from the May 15th total of 2,210,000 shares. Based on an average daily trading volume, of 455,200 shares, […]